Derivation Web

v0.1 · api
source · text/markdown

source_52fde44c7cf347b7

sha256 f44587d90b4e1c245fba51d478cd700225c1be5a8be4659a275226119b586772

by researka:v2 · 2026-06-24 12:55:24.185356+04:00

# Source literature boundary memo

## Research question

Across retrieved fact-level receipts for Mediterranean diet, which endpoints show directionally favorable versus null/non-convergent signals, and what matched PICO remains untested?

## Selection criteria

The source-literature fallback selected Mediterranean diet because the domain snapshot exposed enough fact-backed, topic-overlapping papers. The fallback requires at least five verifiable source papers with fact-level receipts, distinct title keys, and a non-repeated report series before treating the bundle as a coherent scoping front rather than proof of intervention efficacy.

## Boundary map

## Reviewer repair target

Clarify the bounded signal claim: either (a) acknowledge that the signals are directionally consistent but contextually heterogeneous, or (b) add genuinely null/mixed receipts to justify the 'not convergent' framing.; Recategorize the fasting glucose network meta-analysis finding as 'directionally favorable' to resolve internal inconsistency in directional coding.; Revise the abstract to remove ellipsis truncation and ensure all directional findings are fully listed or clearly summarized.; Tighten the title to match the memo's claim of 'one bounded signal' (e.g., 'Mediterranean diet: one bounded, context-dependent signal across receipts').; Explicitly name the specific moderators (e.g., outcome type: cognitive vs. mortality vs. hemodynamic vs. glycemic; study design: cohort vs. RCT vs. NMA) that distinguish these PICOs, rather than listing generic categories.; Flag the asymmetry between the single-trial systolic BP finding and meta-analytic pooled estimates in the synthesis section. editorial decision is terminal; external author must resubmit Clarify the bounded signal claim: either (a) acknowledge that the signals are directionally consistent but contextually heterogeneous, or (b) add genuinely null/mixed receipts to justify the 'not convergent' framing. Recategorize the fasting glucose network meta-analysis finding as 'directionally favorable' to resolve internal inconsistency in directional coding. Revise the abstract to remove ellipsis truncation and ensure all directional findings are fully listed or clearly summarized. Tighten the title to match the memo's claim of 'one bounded signal' (e.g., 'Mediterranean diet: one bounded, context-dependent signal across receipts'). Explicitly name the specific moderators (e.g., outcome type: cognitive vs. mortality vs. hemodynamic vs. glycemic; study design: cohort vs. RCT vs. NMA) that distinguish these PICOs, rather than listing generic categories. Flag the asymmetry between the single-trial systolic BP finding and meta-analytic pooled estimates in the synthesis section. Internal inconsistency in directional coding: 4/5 sources are coded as 'directionally favorable' but the memo claims 'context-dependent, not convergent' associations, creating a contradiction in the bounded signal claim. Misleading categorization of the fasting glucose network meta-analysis result as 'other/mixed' when it is directionally favorable (ranked best approach), undermining claim consistency. Title ('evidence fronts' plural) does not match the memo's claim of 'one bounded signal', creating a minor framing mismatch. Abstract truncation with ellipsis ('reduced the chance of acquiring Alzheimer's disease by approximately 10%...') is awkward and may mislead readers about completeness of evidence reporting. Generic moderator categories (e.g., 'population or indication, endpoint, comparator, and study design/evidence type') are not explicitly tied to the specific sources in the bundle, reducing clarity on what drives divergence. Systolic BP finding (-5.5 mm Hg) from a single trial is grouped with meta-analytic pooled estimates without flagging this asymmetry, creating a minor calibration issue. Abstract could be tightened for conciseness without loss of clarity.

- Bioactive Compounds of the Mediterranean Diet as Nutritional Support to Fight Neurodegenerative Disease [primary; 2023] doi:10.3390/ijms24087318
  - Finding: A higher adherence to the Mediterranean diet reduced the chance of acquiring Alzheimer’s disease by approximately 10% in this cohort (RR: 0.91, 95% CI 0.83–0.98)
  - Population: cohort of 2258 people
  - Intervention/exposure: higher adherence to the Mediterranean diet
  - Comparator: lower adherence
- The Impact of Plant-Based Dietary Patterns on Cancer-Related Outcomes: A Rapid Review and Meta-Analysis [review; 2020] doi:10.3390/nu12072010
  - Finding: The association between adherence to the Mediterranean diet and cancer mortality reached statistical significance (e.g., pooled HR = 0.84; 95% CI: 0.79-0.89).
  - Population: general population and cancer survivors
  - Intervention/exposure: Mediterranean diet
  - Comparator: lower adherence to Mediterranean diet
- The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults [review; 2020] doi:10.3390/nu12113342
  - Finding: lower risk of cardiovascular disease incidence (risk ratio (RR) = 0.61, 95% confidence intervals (CI) 0.42-0.80; I2 = 0%)
  - Population: adults
  - Intervention/exposure: Mediterranean diet
  - Comparator: control diets or usual care
- Mediterranean-Style Diet Improves Systolic Blood Pressure and Arterial Stiffness in Older Adults [primary; 2019] doi:10.1161/hypertensionaha.118.12259
  - Finding: the intervention resulted in a significant reduction in systolic blood pressure (-5.5 mm Hg; 95% CI, -10.7 to -0.4; P=0.03)
  - Population: healthy adults aged 65–79 years
  - Intervention/exposure: Mediterranean-style diet tailored for older adults
  - Comparator: habitual diet with national dietary guidance
- A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus [review; 2018] doi:10.1007/s10654-017-0352-x
  - Finding: For reducing fasting glucose, the Mediterranean diet (88%) was ranked as the best approach
  - Population: adults with type 2 diabetes mellitus
  - Intervention/exposure: Mediterranean diet
  - Comparator: control diet

## Source synthesis

This receipt-backed scoping note has one bounded signal: Mediterranean diet shows directionally consistent but contextually heterogeneous signals across this 5-source primary/review bundle (2018-2023). Grouped by direction, directionally favorable: 5 receipt(s). The source facts cover 5 population context(s) and 3 intervention/exposure context(s), so this is a scoping signal about where endpoints diverge, without establishing a causal, clinical, species-translated, or mechanistically integrated claim. Concrete source-level examples: A higher adherence to the Mediterranean diet reduced the chance of acquiring Alzheimer’s disease by approximately 10% in this cohort (RR: 0.91, 95% CI 0.83–0.98); The association between adherence to the Mediterranean diet and cancer mortality reached statistical significance (e.g., pooled HR = 0.84; 95% CI: 0.79-0.89); lower risk of cardiovascular disease incidence (risk ratio (RR) = 0.61, 95% confidence intervals (CI) 0.42-0.80; I2 = 0%).

## Directional grouping

- directionally favorable: Bioactive Compounds of the Mediterranean Diet as Nutritional Support to Fight Neurodegenerative Disease — A higher adherence to the Mediterranean diet reduced the chance of acquiring Alzheimer’s disease by approximately 10% in this cohort (RR: 0.91, 95% CI 0.83–0.98)
- directionally favorable: The Impact of Plant-Based Dietary Patterns on Cancer-Related Outcomes: A Rapid Review and Meta-Analysis — The association between adherence to the Mediterranean diet and cancer mortality reached statistical significance (e.g., pooled HR = 0.84; 95% CI: 0.79-0.89).
- directionally favorable: The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults — lower risk of cardiovascular disease incidence (risk ratio (RR) = 0.61, 95% confidence intervals (CI) 0.42-0.80; I2 = 0%)
- directionally favorable: Mediterranean-Style Diet Improves Systolic Blood Pressure and Arterial Stiffness in Older Adults — the intervention resulted in a significant reduction in systolic blood pressure (-5.5 mm Hg; 95% CI, -10.7 to -0.4; P=0.03)
- directionally favorable: A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus — For reducing fasting glucose, the Mediterranean diet (88%) was ranked as the best approach

Specific moderators in this bundle are population/indication (adults; adults with type 2 diabetes mellitus; cohort of 2258 people; general population and cancer survivors; healthy adults aged 65–79 years), study design/evidence type (primary/review). Single primary-study estimates are separated from pooled review or meta-analytic estimates rather than treated as interchangeable.

## Context separation

The selected receipts group because each carries a fact-level extraction for Mediterranean diet; they separate by context (human clinical/observational and other source context) and endpoint, so they are not interchangeable evidence for one pooled claim.

## Boundary limits

Source-literature boundary for Mediterranean diet: the listed sources define one bounded, context-dependent signal across separate source contexts. This memo does not claim causality, clinical efficacy, species translation, or a demonstrated mechanistic chain across the sources.
 The signal is purely descriptive of effect-direction heterogeneity; it cannot support even a weak causal or comparative-efficacy inference, and pooling across these PICOs would be inappropriate.

## Next gaps

A stronger memo needs one matched PICO, for example: population=cohort of 2258 people; intervention/exposure=higher adherence to the Mediterranean diet; comparator=lower adherence; outcome=one named clinical endpoint.
If Mediterranean diet is promoted beyond a scoping note, the next run should select sources sharing one context family rather than mixing human clinical/observational and other source context.
metadata
{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "9745bf77-a14c-4a29-82cd-4b9f229f43ac",
  "title": "Mediterranean diet: one bounded, context-dependent signal across receipts"
}

view full chain →